[1] [1] TIWARI S, SETH A. Nephrotic syndrome in children-a tale of 50 years［J］. Indian Pediatrics, 2016, 53(12): 1097-1098.

[11] [11] LI S, ZHANG B. Traditional chinese medicine network pharmacology: theory, methodology and application［J］. Chinese Journal of Natural Medicines, 2013, 11(2): 110-120.

[16] [16] LU H, WU L, LIU L, et al. Quercetin ameliorates kidney injury and fibrosis by modulating M1/M2 macrophage polarization［J］. Biochemical Pharmacology, 2018, 154: 203-212.

[18] [18] BELOFSKY G, KOLACZKOWSKI M, ADAMS E. Fungal ABC transporter-associated activity of isoflavonoids from the root extract of Dalea formosa［J］. Journal of Natural Products, 2013, 76(5): 915-925.

[19] [19] RUKACHAISIRIKUL T, INNOK P, AROONRERK N, et al. Antibacterial pterocarpans from erythrina subumbrans［J］. Journal of Ethnopharmacology, 2007, 110(1): 171-175.

[20] [20] ZHOU H, LUTTEROD H, CHENG Z, et al. Anti-Inflammatory and antiproliferative activities of trifolirhizin, a flavonoid from Sophora flavescens roots［J］. Journal of Agricultural and Food Chemistry, 2009, 57(11): 4580-4585.

[21] [21] MILLER D K, SADOWSKIS S, HAN G Q, et al. Identification and isolation of medicarpin and a substituted benzofuran as potent leukotriene inhibitors in an anti-inflammatory Chinese herb［J］. Prostaglandins Leukot Essent Fatty Acids, 1989, 38(2): 137-143.

[22] [22] ZHANG W W, XU F, W D, et al. Buyang Huanwu decoction ameliorates ischemic stroke by modulating multiple targets with multiple components: in vitro evidences［J］. Chinese Journal of Natural Medicines, 2018, 16(3): 194-202.

[23] [23] KIM I Y, PARK Y K, SONG S H, et al. Akt1 is involved in tubular apoptosis and inflammatory response during renal ischemia-reperfusion injury［J］. Molecular Biology Reports, 2020, 47(12): 9511-9520.

[24] [24] LIN H Y, CHEN Y, CHEN Y H, et al. Tubular mitochondrial AKT1 is activated during ischemia reperfusion injury and has a critical role in predisposition to chronic kidney disease［J］. Kidney International, 2021, 99(4): 870-884.

[25] [25] YAKULOV T A, TODKAR A P, SLANCHEV K, et al. CXCL12 and MYC control energy metabolism to support adaptive responses after kidney injury［J］. Nature Communications, 2018, 9(1): 3660.

[26] [26] HUANG B, MU P, CHEN X, et al. Aflatoxin B1 induces S phase arrest by upregulating the expression of p21 via MYC, PLK1 and PLD1［J］. Biochemical Pharmacology, 2019, 166: 108-119.

[27] [27] TANG C, MA Z, ZHU J, et al. P53 in kidney injury and repair: mechanism and therapeutic potentials［J］. Pharmacology & Therapeutics, 2019, 195: 5-12.

[28] [28] HE L, WEI Q, LIU J, et al. AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms［J］. Kidney International, 2017, 92(5): 1071-1083.

[29] [29] REN Q, GUO F, TAO S, et al. Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice［J］. Biomed & Pharmacotherapy, 2020, 122: 109772.

[30] [30] ZHANG H F, WANG Y L, GAO C, et al. Salvianolic acid A attenuates kidney injury and inflammation by inhibiting NF-κB and p38 MAPK signaling pathways in 5/6 nephrectomized rats［J］. Acta Pharmacologica Sinica, 2018, 39(12): 1855-1864.

[31] [31] LI R, GUO Y, ZHANG Y, et al. Salidroside ameliorates renal interstitial fibrosis by inhibiting the TLR4/NF-κB and MAPK signaling pathways［J］. Inernational Journal of Molecular Sciences, 2019, 20(5): 1103.

[32] [32] HAN F, GAO Y, DING C G, et al. Knockdown of NLRC5 attenuates renal I/R injury in vitro through the activation of PI3K/Akt signaling pathway［J］. Biomedicine & Pharmacotherapy, 2018, 103: 222-227.

[33] [33] DOU F, LIU Y, LIU L, et al. Aloe-emodin ameliorates renal fibrosis via inhibiting PI3K/Akt/mTOR signaling pathway in vivo and in vitro［J］. Rejuvenation Research, 2019, 22(3): 218-229.

[34] [34] LINDSTROM N O, CARRAGHER N O, HOHENSTEIN P. The PI3K pathway balances self-renewal and differentiation of nephron progenitor cells through β-catenin signaling［J］. Stem Cell Reports, 2015, 4(4): 551-560.

[35] [35] LUO T T, LU Y, YAN S K, et al. Network pharmacology in research of Chinese medicine formula: methodology, application and prospective［J］. Chinese Journal of Integrative Medicine, 2020, 26(1): 72-80.